2014

Solta Medical Reschedules Third Quarter 2012 Results Release and Conference Call to November 1, 2012 Due to Severe Weather Conditions

HAYWARD, Calif., Oct. 29, 2012 /PRNewswire/ -- Solta Medical, Inc. (NASDAQ: SLTM), a global leader in the medical aesthetics market, today announced that it has rescheduled the release of its financial results and conference call for the third quarter ended September 30, 2012, to November 1, 2012 due to the unexpected severe weather conditions associated with Hurricane Sandy.

The Company will release its third quarter 2012 results before the market opens on Thursday, November 1, 2012.  The Company will host a conference call and webcast on Thursday, November 1, 2012, at 10:30 a.m. Eastern Time (7:30 a.m. Pacific) to discuss the financial results and current corporate developments.  The dial-in number for the conference call is 877-941-6009 for domestic participants and 480-629-9819 for international participants.

To access the live webcast of the call, go to Solta Medical's website at www.solta.com and click on Investor Relations.  An archived webcast will also be available at www.solta.com

About Solta Medical, Inc.

Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers six aesthetic energy devices to address a range of issues, including skin resurfacing and rejuvenation with Fraxel® and Clear + Brilliant™, body contouring and skin tightening with Liposonix® and Thermage® and acne reduction with Isolaz® and CLARO™. As the innovator and leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun-damaged skin. Using similar fractional laser technology, Clear + Brilliant is a unique, cost-effective treatment to prevent and improve the early signs of photoaging. For body contouring, Liposonix is a non-surgical treatment to reduce waist circumference with advanced high-intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat beneath the skin. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. Isolaz was the first laser or light-based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA-cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. More than two million procedures have been performed with Solta Medical's portfolio of products around the world. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com.

© 2012 Solta Medical, Inc. All rights reserved. Thermage, Fraxel, Isolaz, Clear + Brilliant, CLARO, Liposonix and Solta Medical are trademarks or registered trademarks of Solta Medical, Inc. or its subsidiaries.

Web Site: http://www.Solta.com

SOURCE Solta Medical, Inc.



RELATED LINKS
http://www.solta.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.